Ushbu ishga iqtibos qilgan ishlar

2 ta ish

Ish: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

1. CAR-T cell combination therapy: the next revolution in cancer treatment

   Maysoon Al‐Haideri, Santalia Banne Tondok, Salar Hozhabri Safa +8

   Sharh maqolaCAR-T cell therapy researchCancer Cell International20222 iqtibos

   ABIABI:AkademIndex/openalex/2022.review-article.000004

2. Epigenetic insights and innovations for overcoming barriers in CAR-T cell therapy for cancer

   Viktoria B. Poluektova, Svetlana N. Zuevskaya, Yarmatov Suvon +3

   MaqolaCAR-T cell therapy researchClinical & Translational Oncology20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.008555